Stock Events

Stock Events

Scinai Immunotherapeutics 

$0.3310
17
+$0.01+1.81% Friday 20:00

Statistics

Day High
0.378
Day Low
0.3002
52W High
2.56
52W Low
0.3251
Volume
1,211,231
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Financials

728.88%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
1.32MRevenue
9.59MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCNI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical method development, process development, and cGMP manufacturing of clinical-stage materials to early-stage biotechnology companies. It has collaboration partnerships with Max Planck Society and University Medical Center Gottingen for the development of NanoAb candidates; and Recipharm Israel Ltd for the development of biologics and small-molecule programs. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is based in Jerusalem, Israel.
Show more...
CEO
Mr. Amir Reichman M.B.A., M.Sc.
Employees
31
Country
Israel
ISIN
US09073Q3039

Listings

STU
DE
2F5.STU
MU
DE
2F5.MU
F
DE
2F5.F
XNAS
US
SCNI

0 Comments

Share your thoughts

FAQ

What is Scinai Immunotherapeutics stock price today?▼
The current price of SCNI is $0.33 USD — it has increased by +1.81% in the past 24 hours. Watch Scinai Immunotherapeutics stock price performance more closely on the chart.
What is Scinai Immunotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Scinai Immunotherapeutics stocks are traded under the ticker SCNI.
Is Scinai Immunotherapeutics stock price growing?▼
SCNI stock has fallen by -19.66% compared to the previous week, the month change is a -34.58% fall, over the last year Scinai Immunotherapeutics has showed a -85.09% decrease.
What is Scinai Immunotherapeutics revenue for the last year?▼
Scinai Immunotherapeutics revenue for the last year amounts to 1.32M USD.
What is Scinai Immunotherapeutics net income for the last year?▼
SCNI net income for the last year is 9.59M USD.
How many employees does Scinai Immunotherapeutics have?▼
As of June 13, 2026, the company has 31 employees.
In which sector is Scinai Immunotherapeutics located?▼
Scinai Immunotherapeutics operates in the Technology sector.
When did Scinai Immunotherapeutics complete a stock split?▼
The last stock split for Scinai Immunotherapeutics was on May 21, 2024 with a ratio of 1:10.
Where is Scinai Immunotherapeutics headquartered?▼
Scinai Immunotherapeutics is headquartered in Jerusalem, Israel.